Fresenius Medical Care | FME - Cost Of Sales

Stock Price
39.32
Daily Change
0.10 0.25%
Monthly
5.50%
Yearly
-15.26%
Q1 Forecast
40.13

Fresenius Medical Care reported EUR3.68B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Akzo Nobel EUR 1.44B 84M Dec/2025
Alcon AG USD 1.16B 52M Sep/2025
AstraZeneca USD 3.27B 471M Dec/2025
Bayer EUR 4.31B 57M Sep/2025
Beiersdorf EUR 2.11B 130M Jun/2025
DaVita Healthcare Partners USD 2.6B 263.46M Dec/2025
Demant DKK 2.89B 188M Dec/2025
E.ON EUR 11.33B 285M Sep/2025
Essilor EUR 6.06B 741M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.68B 38.37M Dec/2025
Genmab DKK 57M 15M Jun/2025
Getinge SEK 6.02B 1.7B Dec/2024
Givaudan CHF 1.05B 936.5M Jun/2024
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GN Store Nord DKK 2.24B 338M Dec/2025
GRIFOLS EUR 1.13B 15.63M Sep/2025
Hikma Pharmaceutical USD 466.5M 428.5M Jun/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.1B 123M Sep/2025
Novartis USD 3.54B 217M Sep/2025
Philips EUR 2.81B 417M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
RWE EUR 2.48B 938M Sep/2025
Sanofi EUR 4.29B 421M Dec/2025
SAP EUR 2.56B 1.49B Dec/2025
Smith & Nephew USD 870M 17M Dec/2025